VRNA

Verona Pharma
VRNA

Overview Fund Activity

15 hedge funds and large institutions have $92.3M invested in Verona Pharma in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.

Holders
15
Holders Change
+1
Holders Change %
+7.14%
% of All Funds
0.34%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
2
Increased
–
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
A
1
Abingworth
United Kingdom
$11.3M
2
FCMI
2
Foresite Capital Management IV
California
$104K

Top Sellers

1
PA
1
Perceptive Advisors
New York
$0
2
FCMI
2
Foresite Capital Management III
California
$6.27M
3
Deutsche Bank
3
Deutsche Bank
Germany
$80K
Name Market Value Shares Shares
Change 		Shares
Change %
VC
1
Vivo Capital
California
$18.7M 1,492,951 – –
O
2
OrbiMed
New York
$15.6M 1,250,396 – –
NMC
3
NEA Management Company
Maryland
$15.3M 1,219,674 – –
A
4
Abingworth
United Kingdom
$11.3M 901,943 +901,943 New
VP
5
venBio Partners
California
$10.9M 875,000 – –
NHAS
6
Novo Holdings A/S
Denmark
$9.27M 740,740 – –
FCMI
7
Foresite Capital Management III
California
$6.27M 500,883 -1,942 -0.4%
TCM
8
Tekla Capital Management
Massachusetts
$3.44M 275,000 – –
PC
9
Polar Capital
United Kingdom
$1.25M 100,000 – –
FCMI
10
Foresite Capital Management IV
California
$104K 8,302 +8,302 New
Deutsche Bank
11
Deutsche Bank
Germany
$80K 6,417 -50 -0.8%
US Bancorp
12
US Bancorp
Minnesota
$48K 3,840 – –
OSNBOA
13
Old Second National Bank of Aurora
Illinois
$19K 1,481 – –
TRCT
14
Tower Research Capital (TRC)
New York
$3K 255 – –
PA
15
Perceptive Advisors
New York
– – -22,327 Closed
Morgan Stanley
16
Morgan Stanley
New York
$0 1 – –
CFGS
17
Concourse Financial Group Securities
Alabama
– – – –